Mark Yang, PhDVP of CMC at Palleon PharmaceuticalsSpeaker
Profile
Dr. Yang is Vice President of CMC at Palleon Pharmaceuticals Inc., where he works for the last 4 years and oversees all CMC related activities, including cell line development, cell culture, purification, formulation, analytics, GMP manufacturing, IND submission, and CDMO management. Prior to Palleon, Dr. Yang was the Director of Global Pharmaceutic Development Biologics in Sanofi for 10 years, where he led a team responsible for drug product process development, process scale up, CTM manufacturing, IND/IMPD/BLA submission, and product commercial launch. Dr. Dr. Yang also worked for many years in protein formulation, drug delivery, and GMP manufacture support in Acceleron, Baxter and Altus. He is the recipient of VP Award from Sanofi Genzyme, Outstanding Technology Achievement Award from Baxter, and Fellows Award for Research Excellence from NIH. Besides numerous patents, he published over two dozen peer-reviewed research papers in many prestigious journals.
Agenda Sessions
Considerations to Develop a Right Formulation and Dosage Form for Biotherapeutics for Your First-In-Human Clinial Trial
, 11:00amView Session